Visual acuity and diabetic maculopathy

Annals of Ophthalmology

Volumn 38, Issue 4, 2006, Pages 305-310

  Ang, Ghee S ^a   Vusirikala, Bharati ^a   Mukherji, Subhanjan ^a   Ram, Aji R Raghu ^a  

^a ROYAL GLAMORGAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; DIABETIC MACULOPATHY; GLYCOSYLATION; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; RETINA MACULOPATHY; SCREENING; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; DIABETIC RETINOPATHY; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MACULAR DEGENERATION; MIDDLE AGED; RETROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 34948903352     PISSN: 15304086     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02697212     Document Type: Article

References (17)

1. Bailey CC, Sparrow JM. Visual symptomatology in patients with sight-threatening diabetic retinopathy. Diabet Med 2001;18:883-888.
2. Harding SP, Broadbent DM, Neoh C, et al. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study. BMJ 1995;311:1131-1135.
3. Klein BE, Moss SE, Klein R, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudates. Ophthalmology 1991;98:1261-1265.
4. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1769-1806.
5. Zander E, Herfurth S, Bohl B, et al. Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors. Br J Ophthalmol 2000;84:871-876.
6. Voutilainen-Kaunisto R, Teräsvirta M, Uusitupa M, et al. Maculopathy and visual acuity in newly diagnosed type 2 diabetic patients and non-diabetic subjects: A 10-year follow-up study. Acta Ophthalmol Scand 2001;79:163-168.
7. Bek T, Møller F, Klausen B. Short term visual prognosis after retinal laser photocoagulation for diabetic maculopathy. Acta Ophthalmol Scand 2000;78:539-542.
8. Bailey CC, Sparrow JM, Grey RHB, et al. The National Diabetic Retinopathy Laser Treatment Audit. I. Maculopathy. Eye 1998;12:69-76.
9. Bailey CC, Sparrow JM, Grey RHB, et al. The National Diabetic Retinopathy Laser Treatment Audit. III. Clinical outcomes. Eye 1999;13:151-159.
10. Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 1991;98:1594-1602.
11. Stefaniotou M, Kalogeropoulos C, Psilas K. Long-term visual results after laser photocoagulation for diabetic maculopathy. Ophthalmologica 1995;209:64-67.
12. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853.
13. National Institute for Clinical Excellence. Management of type 2 diabetes: blood glucose 2002. National Institute for Clinical Excellence: London.
14. Knudsen ST, Bek T, Poulsen PL, et al. Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy. Diabetes Care 2002;25:2328-2334.
15. The Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial. Diabetes 1996;45:1289-1298.
16. Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-412.
17. Kube T, Schmidt S, Toonen F, et al. Fixation stability and macular light sensitivity in patients with diabetic maculopathy: a microperimetric study with scanning laser ophthalmoscope. Ophthalmologica 2005;219:16-20.